GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Med-X Systems Inc (OTCPK:MXSS) » Definitions » Research & Development

Med-X Systems (Med-X Systems) Research & Development : $ Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Med-X Systems Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Med-X Systems's Research & Development for the three months ended in . 20 was $0.00 Mil. Med-X Systems does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


Med-X Systems Research & Development Historical Data

The historical data trend for Med-X Systems's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Med-X Systems Research & Development Chart

Med-X Systems Annual Data
Trend
Research & Development

Med-X Systems Quarterly Data
Research & Development

Med-X Systems Research & Development Calculation

This is the expense the company spent on research and development.


Med-X Systems  (OTCPK:MXSS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Med-X Systems Research & Development Related Terms

Thank you for viewing the detailed overview of Med-X Systems's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Med-X Systems (Med-X Systems) Business Description

Traded in Other Exchanges
N/A
Address
Website

Med-X Systems (Med-X Systems) Headlines

No Headlines